Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group

Author：

Publisher： Informa Healthcare

ISSN： 1473-3404

Source： The Women's Oncology Review, Vol.4, Iss.3, 2004-09, pp. : 241-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy

By Pierce Lori

Breast Cancer Research and Treatment, Vol. 121, Iss. 2, 2010-06 ,pp. : 389-398

Springer Publishing Company

Access to resources Recommend Favorite

The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer

By Narod Steven

Breast Cancer Research and Treatment, Vol. 128, Iss. 2, 2011-07 ,pp. : 581-583

Springer Publishing Company

Access to resources Recommend Favorite

Appendectomy and cancer risk in Jewish BRCA1 and BRCA2 mutation carriers

By Bernholtz Shiri

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 981-985

Springer Publishing Company

Access to resources Recommend Favorite

The CYP17A1 −34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers

By Kaufman Bella

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 521-527

Springer Publishing Company

Access to resources Recommend Favorite

Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

By Kotsopoulos Joanne

Cancer Causes and Control, Vol. 16, Iss. 6, 2005-08 ,pp. : 667-674

Springer Publishing Company

Access to resources Recommend Favorite